THIS EDUCATIONAL SERIES OF VIDEOS IS DESIGNED TO SUPPORT HEALTHCARE PROFESSIONALS IN ENHANCING DIABETES MANAGEMENT THROUGH INNOVATIVE TECHNOLOGY
Watch our first insightful video now featuring Dr. Edelman and Dr. Ahn, who explain the differences between the transcutaneous and implantable continuous glucose monitors. By the end of the video, you will be well-equipped to understand and offer your patients a choice of which type of CGM is best for their personal lifestyle.
LEARN ALL ABOUT THE EVERSENSE IMPLANTABLE CGM
Understanding Eversense Implantable CGM:
• Extended Wear Period: Up to 180 days of use
• On-Body Vibratory Alerts: Alternative notification method
• Unique Form Factor: Implantable sensor with removable transmitter
• Prescription Efficiency: Fewer sensor changes mean reduced prescription hassles for patients and healthcare providers like you
• Calibration Requirements: Periodic calibration needed for the accuracy of the sensor
• Potential for Reduced Skin Irritation: Gentle silicon adhesive
• Alternative for Active Lifestyles: Option for water sports enthusiasts
What type of patients might consider the Eversense Implantable Sensor?
• Patients with type 1 or type 2 diabetes on insulin therapy
• Those with active lifestyles or specific workplace requirements
• Individuals seeking alternative options between other available CGM systems
MEET YOUR EXPERT SPEAKERS
Here at TCOYD®, we create educational diabetes content to support both healthcare professionals and individuals living with diabetes. Taking a proactive role in learning about the latest diabetes technology is vital to choosing the right tools to help you stay at the forefront of patient care. Dr. Steve Edelman, who has lived with diabetes for 54 years, has experienced it all. He is sharing his thoughts with Dr. David Ahn, an experienced endocrinologist so that you can stay updated on diabetes technology.
STEVEN V. EDELMAN, MD
Endocrinologist, Founder & Director of TCOYD®; Professor of Medicine, UCSD School of Medicine, VA Medical Center, San Diego, California; Board Member, Senseonics
DAVID AHN, MD
Endocrinologist; Chief of Diabetes Services, Hoag Medical Group, Newport Beach, California
SAVE THIS PAGE TO SEE OUR FUTURE EPISODES!
